Announced Mon, 16 Jun · 18:24 IST

As detailed in the letter attached herewith.

Corporate Actions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board of Fundviser Capital approved raising the authorized share capital from Rs. 10 crore to Rs. 12.5 crore. It also approved issuing 64,85,000 convertible warrants at Rs. 116 each (a premium of Rs. 106 over the face value of Rs. 10) on a preferential basis to promoter group entities and strategic non-promoter investors, aggregating to roughly Rs. 75.23 crore. An Extraordinary General Meeting has been scheduled for 15th July 2025 to seek shareholder approval. Separately, Chairman Prem Krishan Jain was redesignated from Whole Time Director to Managing Director until 31st March 2026. The warrants require only 25% upfront payment and are convertible into equity within 18 months.

Likely market impact

This is a capital-raising move that will dilute existing shareholders once the warrants are converted into equity shares, unless they participate in the preferential allotment. Promoter and select investor groups are receiving warrants at a premium, signaling confidence but also potential equity dilution for retail holders.